Aptose Biosciences Inc.·4

Feb 3, 9:52 PM ET

Vincent Mark D. 4

4 · Aptose Biosciences Inc. · Filed Feb 3, 2020

Insider Transaction Report

Form 4
Period: 2020-01-31
Transactions
  • Award

    Director Option Grant

    2020-01-31+154,000154,000 total
    Exercise: $6.91Exp: 2030-01-30Common Shares (154,000 underlying)
Footnotes (2)
  • [F1]Converted from Canadian exercise price of C$9.10 using an exchange rate of 1.3169.
  • [F2]Fifty percent (50%) of the options vest on 1/31/2021. The remaining 50% vest as follows: one-half on 1/31/2022 and one-half on 1/31/2023.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4